Company news

Cerus Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

March 25, 2024

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

March 18, 2024

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

March 4, 2024

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

February 19, 2024

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

January 7, 2024

Cerus Corporation Announces Third Quarter 2023 Financial Results

November 1, 2023

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

October 18, 2023

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

October 9, 2023

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

September 26, 2023

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

September 11, 2023

Cerus Corporation Announces Second Quarter 2023 Financial Results

August 1, 2023

Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023

July 18, 2023

Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress

June 14, 2023

Cerus Corporation Celebrates World Blood Donor Day 2023

June 13, 2023

Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

June 4, 2023

Cerus Corporation Announces First Quarter 2023 Financial Results

May 3, 2023

Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

April 19, 2023

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results

February 27, 2023

Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 14, 2023

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update

January 8, 2023

Cerus Corporation Announces Third Quarter Financial Results

November 2, 2022

Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

November 1, 2022

Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage

October 31, 2022

Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022

October 19, 2022

Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting

September 25, 2022

Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency

August 11, 2022

Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range

August 3, 2022

Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022

July 20, 2022

Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors

July 4, 2022

Cerus Corporation Celebrates World Blood Donor Day 2022

June 13, 2022

Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range

May 4, 2022

Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets

May 2, 2022

Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross

April 24, 2022

Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022

April 20, 2022

Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference

February 24, 2022

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results

February 21, 2022

Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022

February 7, 2022

Cerus Corporation to Participate in Upcoming Virtual Investor Conferences

February 6, 2022

Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update

January 9, 2022

Cerus Corporation to Participate in Stephens Annual Investment Conference

November 18, 2021

Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference

November 7, 2021

Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance

November 1, 2021

Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021

October 18, 2021

Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply

September 30, 2021

Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021

September 19, 2021

Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference

September 14, 2021

Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products

August 9, 2021

Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors

August 3, 2021

Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance

August 2, 2021

Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex

August 2, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks